NPPA notified regarding the computation of the retail price of Glimepiride IP 2mg + Metformin Hydrochloride IP 1000mg (as sustained release form) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s German Remedies Pharmaceuticals Pvt Ltd (Marketer)

Feb 20, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 19, 2025, was notified regarding the computation of the retail price Glimepiride IP 2mg + Metformin Hydrochloride IP 1000mg (as sustained release form) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s German Remedies Pharmaceuticals Pvt Ltd (Marketer).

It states that the price of each uncoated bilayered tablet containing: Glimepiride IP 2mg + Metformin Hydrochloride IP 1000mg (as sustained release form) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s German Remedies Pharmaceuticals Pvt Ltd (Marketer) has been revised to Rs. 11.58/-.

[Notification no: 19(4318)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT